Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome

Benzer Materyaller

• Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials
  Yazar:: Seidner, Douglas L., ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Effect of Teduglutide, a Glucagon-like Peptide 2 Analog, on Citrulline Levels in Patients With Short Bowel Syndrome in Two Phase III Randomized Trials
  Yazar:: Seidner, Douglas L, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Long-Term Teduglutide for the Treatment of Patients With Intestinal Failure Associated With Short Bowel Syndrome
  Yazar:: Schwartz, Lauren K, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Teduglutide for short bowel syndrome
  Baskı/Yayın Bilgisi: (2020)
• Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients
  Yazar:: Jeppesen, P B, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)